Brief: OncoZenge Extends Payment Deadline In Directed Share Issue
BRIEF-OncoZenge Extends Payment Deadline In Directed Share Issue July 13 (Reuters) - OncoZenge AB (publ) ONCOZ.ST:
SAID ON FRIDAY CO RECEIVED PARTIAL PAYMENT OF SEK 5.0 MILLION OF SUBSCRIPTION PROCEEDS IN DIRECTED SHARE ISSUE OF ABOUT SEK 15.1 MILLION TO SICHUAN YANGTIAN BIO-PHARMACEUTICAL
ABOUT SEK 10.1 MILLION REMAINS OUTSTANDING, AND BOARD RESOLVED TO EXTEND PAYMENT DEADLINE FOR THIS REMAINING AMOUNT TO JULY 17, 2026
VIEWS EXTENSION AS ADMINISTRATIVE IN NATURE, WITH NO EXPECTED ADVERSE IMPACT ON CO'S LIQUIDITY OR FINANCIAL POSITION
Source text for Workspace: nMFNThK8g
Further company coverage: ONCOZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))